115 related articles for article (PubMed ID: 24024535)
21. [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].
Iglesias Garcia C; Santamarina Montila S; Alonso Villa MJ
Actas Esp Psiquiatr; 2006; 34(4):277-9. PubMed ID: 16823689
[TBL] [Abstract][Full Text] [Related]
22. Drug use in nursing homes: some new evidence.
Mant A; Donnelly NJ
Med J Aust; 1996 Sep; 165(5):295-6. PubMed ID: 8816695
[No Abstract] [Full Text] [Related]
23. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
24. Abuse of psychopharmacological drugs--experiences in Norway.
Retterstöl N
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):18-23. PubMed ID: 4154739
[No Abstract] [Full Text] [Related]
25. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.
Villari V; Frieri T; Fagiolini A
J Clin Psychopharmacol; 2011 Jun; 31(3):375-6. PubMed ID: 21532362
[No Abstract] [Full Text] [Related]
26. Selective sound intolerance and emotional distress: what every clinician should hear.
Hadjipavlou G; Baer S; Lau A; Howard A
Psychosom Med; 2008 Jul; 70(6):739-40. PubMed ID: 18596245
[No Abstract] [Full Text] [Related]
27. The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
Mahgoub N; Asemota B; Alexopoulos GS
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E24-5. PubMed ID: 21677213
[No Abstract] [Full Text] [Related]
28. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder.
Poyurovsky M
Isr J Psychiatry Relat Sci; 2008; 45(3):219-20. PubMed ID: 19398826
[No Abstract] [Full Text] [Related]
29. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
[TBL] [Abstract][Full Text] [Related]
30. Recent developments in the use of antidepressant and anxiolytic medications.
Simeon JG; Ferguson HB
Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
[TBL] [Abstract][Full Text] [Related]
31. Management of comorbid anxiety and depression.
Zajecka JM; Ross JS
J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
[TBL] [Abstract][Full Text] [Related]
32. How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.
Preskorn SH
J Psychiatr Pract; 2008 May; 14(3):170-5. PubMed ID: 18520787
[No Abstract] [Full Text] [Related]
33. Rational use of psychotropic drugs. II. Antianxiety agents.
Greenblatt DJ; Shader RI
J Maine Med Assoc; 1974 Sep; 65(9):225-9. PubMed ID: 4153460
[No Abstract] [Full Text] [Related]
34. Urinary retention with sertraline, haloperidol, and clonazepam combination.
Benazzi F
Can J Psychiatry; 1998 Dec; 43(10):1051-2. PubMed ID: 9868574
[No Abstract] [Full Text] [Related]
35. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
Correll CU; Kratochvil CJ; March JS
J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
[TBL] [Abstract][Full Text] [Related]
36. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
Towbin KE; Leckman JF; Cohen DJ
Psychiatr Dev; 1987; 5(1):25-50. PubMed ID: 2885832
[TBL] [Abstract][Full Text] [Related]
37. Psychopharmacology in Primary Care Settings.
Benich JJ; Bragg SW; Freedy JR
Prim Care; 2016 Jun; 43(2):327-40. PubMed ID: 27262011
[TBL] [Abstract][Full Text] [Related]
38. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
[TBL] [Abstract][Full Text] [Related]
39. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
40. Obsessive-compulsive disorder: a treatment review.
Perse T
J Clin Psychiatry; 1988 Feb; 49(2):48-55. PubMed ID: 2892831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
